adjunctive corticosteroid therapy in tuberculosis management
TRANSCRIPT
![Page 1: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/1.jpg)
ADJUNCTIVE CORTICOSTEROID THERAPY IN TUBERCULOSIS MANAGEMENT
![Page 2: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/2.jpg)
INTRODUCTIONThe effectiveness of corticosteroids against
M.Tuberculosis was studied earlier in animal models of tuberculosis & it was found that in those animals who didn’t receive any specific antituberculous therapy, the virulence of M.tuberculosis was enhanced markedly by corticosteroid administration.
Corticosteroids when used in conjuction with effective antitubercular therapy has been benefecial in milliary tuberculosis, tuberculous meningitis, tuberculous pericarditis.
![Page 3: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/3.jpg)
Corticosteroids improve the outcome in tuberculosis by suppressing the host mediated inflammation.
Adjunctive corticosteroid therapy may be life saving in patients with miliary tuberculosis, is little doubtful.
It has been appreciated that steroid therapy given to patients with untreated or unrecognized tuberculosis results in overwhelming disease and death.
Eleanor Roosevelt died of undiagnosed miliary tuberculosis while being treated with steroid for what was thought to be sarcoidosis.
![Page 4: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/4.jpg)
When to use steroids in tuberculosisDefinite indications: CNS tuberculosis Pericardial tuberculosis Adrenal insufficiencyOther reasonable indications: IRIS/Paradoxical response Far advanced pulmonary TB with severe systemic and
respiratory morbidity Severe cutaneous hypersensitivity reactions to anti-TB
drugs Persistent fever even after 3-4 weeks of T/t Bronchial obstruction Miliary TB with toxemia
![Page 5: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/5.jpg)
Other indications: BCG scar keloid Sick/elderly/extensive primary TB with
large pleural effusion Tubercular pneumonia with acute
respiratory failure Tubercular sarcoidosis Lymph node TB ? Laryngeal TB ? Genitourinary TB ? TB in HIV positive patients
![Page 6: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/6.jpg)
Steroids for TBMCorticosteroids improve outcome as these:• Decrease inflammation, especially in the
subarachnoid space.• Reduce cerebral and spinal cord edema• Reduce inflammation of small bllod
vessels and therefore reduce damage from blood flow slowing to the underlying brain tissue.
![Page 7: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/7.jpg)
Corticosteroids therapy based upon urgent warning signs:Patients who are progressing from one stage to the next at or before the introduction of chemotherapy, especially if associated with any of the conditions – a. Patients with acute “encephalitis”
presentation, especially if the CSF opening pressure is > 400 mmH2O or if there is clinical or CT evidence of cerebral edema.
b. Exacerbation of clinical signs (eg. Fever, change in mentation) after beginning ATT.
![Page 8: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/8.jpg)
c. spinal block or incipient block ( CSF proein >500 mg/dl and rising )d. Head CT evidence of marked basillar enhancement or moderate or advancing hydrocephaluse. Patients with intracerebral tuberculoma, where edema is out of proportion to the mass effect and there are any clinical neurologic signs.
![Page 9: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/9.jpg)
Recommended dosage regimen of corticosteroid in TBM
Stage 1 GCS score – 15, no focal neurological deficit
Total duration – 6 wksInj. Dexamethasone .3mg/kg i.v. day1-7; .2mg/kg day8-14; .1mg/kg day15-21 f/b tab. Dexamethasone3mg/day orally days 22-282mg/day orally days 29-351mg/kg orally days 36-42
![Page 10: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/10.jpg)
Stage 2&3Stage 2 – GCS-11-14; or focal neurological deficit presentStage 3 – GCS <11
Total duration 8wksInj.dexamethasone .4mg/kg i.v. day 1-7; .3mg/kg day 8-14 , .2 mg/kg day 15-21; .1mg/kg day 22-28 f/b tab. Dexamethasone 4mg/day orally days 29-353mg/day orally days 36-422mg/kg orally days 43-491mg/day orally days 50-56
![Page 11: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/11.jpg)
Steriod in pericardial TBIn early stages of pericardial TB
corticosteroid therapy decreases fluid accumulation, decrease need for procedure and even in late stage improve symptomatic & hemodynamic recovery.
In a study : active effusive TB pericarditis the mortality rate was 3% vs 14% & reduced need for reduced need for repeated pericardiocentesis 7of 76 vs 17 of 74.
![Page 12: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/12.jpg)
Steroids for pulmonary TBThe summary of 11 RCTs of steroids use in PTB is: Clinical condition improve more rapidaly
(effects more pronounced in severely ill)Absence of long term benefecial effectFaster radiological responseMinority of patient may have rebound if
steroid discontinued too abruptly.Steroids administration in the face of
inadequate ATT appears harmfull to patients.
![Page 13: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/13.jpg)
Steroids in pleural TBCorticosteroids in pleural TB reduces the
fibrotic sequele, early resolution of clinical symptoms & signs.
Steroids in pleural TB are reserved for patients with large effusions, dyspnoea &/or disabling chest pain and elder patient.
Benefits are more palliative and temporary and systemic steroids are superior to local steroids.
![Page 14: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/14.jpg)
Steroids in HIV-TB diseaseSignificant decrease in generalized
lymphadenopathy and cough at 2 months but undesirable increase in H.zoster and Kaposi sarcoma.
There was no difference in survival at 1 year.
Data do not support use of steroids in reducing morbidity and mortality due to TB directly or influencing survival due to slowing of HIV progression.
![Page 15: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/15.jpg)
Steroids in milliary TBStudy from China in 1981
suggest non significant trend toward better outcome in steroid group than for controls.
Available data suggest a lack of effect of steroid on acute milliary TB & severely ill patient needs.
![Page 16: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/16.jpg)
Adesonian crisis during ATTsome patients of post-primary TB may
have true addison disease; stress of infection & use of ‘rifampicin’ may cause adrenal failure.
![Page 17: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/17.jpg)
Steroid in endobronchial obstruction
Steroids causes reduction in bronchial compression; favourable response in radiographic & bronchoscopic appearance.
Use depends upon degree, site & nature of obstruction.
![Page 18: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/18.jpg)
Steroids in lymph node TBOne third nodes involved in
tubercular peripheral lymphadenopathy ‘flare’ with an exacerbation of pain & swelling after starting ATT.
Intralesional/Intralymphnodal depot steroid therapy may be benefecial in Hilar/mediastinal lymphadenopathy with pressure symptoms.
![Page 19: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/19.jpg)
Steroids in laryngeal TBLaryngeal TB usually responds to
voice rest & ATT.Short course prednisolone may
be use in severe pain.There are lack of datas to
support their use.
![Page 20: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/20.jpg)
Steroids in ATT induced feverDrug fever is not uncommon with
use of ATT.Fever is usually due to INH or
Rifampicin.Patients usually presents with
fever, increase transaminases level & relative bradycardia.
Serial ESR measurement important.
ATT induced fever promptly responds to prednisolone.
![Page 21: Adjunctive corticosteroid therapy in tuberculosis management](https://reader035.vdocuments.site/reader035/viewer/2022070519/58ec98c31a28ab39218b46e7/html5/thumbnails/21.jpg)
Steroids in cutaneous hypersensitivity to drugs
Anti-TB drugs can cause SJ syndrome & TEN, severe reaction may require systemic steroids.